News
Genio is a different approach to hypoglossal nerve stimulation (HGNS) for the treatment of OSA. Genio’s unique design ...
19h
Zacks Investment Research on MSNNyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
Nyxoah NYXH recently received FDA approval for its Genio system, an innovative therapy for moderate to severe Obstructive Sleep Apnea (OSA). Featuring a leadless, battery-free design powered by an ...
4d
InvestorsHub on MSNNyxoah Shares Climb Following FDA Clearance of Genio Device for Sleep Apnea Treatment
Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat ...
The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.
“AI can be used as a gym – a place for training, challenge, and growth – or as a diet pill, a way to bypass effort in the ...
The FDA has approved the Genio® system for treating patients with moderate to severe obstructive sleep apnea (OSA) with an ...
Genio also unveiled The Confident Notetaker's Masterclass, an hour-long, tool-agnostic interactive course created by learning experts that teaches participants techniques and strategies to enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results